In the interplay between the RAAS and ANP in HF, the approaches used in experimental and clinical medicine have included the decrease in the activity of the RAAS by means of ACE inhibitors, ARBs and MRA or increasing the activity of ANP or its second messenger, cGMP or a combination of both approaches. This evidence concerns the gene NPPA and hydrops fetalis.